Infosys commissioned Branded Research, an independent market research firm, to conduct the survey across Australia, China, France, Germany, India, the United Kingdom and the United States. For the survey, Branded Research asked 1,053 C-suite executives and IT decision makers about AI implementation and execution at their organizations.
Here are four things to know about AI in the healthcare and life sciences industry.
1. Fifty-one percent of respondents said the industry was already experiencing “disruption” due to AI technologies.
2. Telecommunication and communication services providers were most likely (65 percent) to indicate their industry had experienced disruption from AI, while the public sector was least likely (34 percent) to do so.
3. The majority of respondents in the healthcare and life sciences industry (72 percent) indicated they use AI to automate business processes.
4. However, 61 percent of healthcare and life sciences respondents reported their organization had difficulty finding qualified staff to lead integration efforts for AI technologies.
To access the Infosys report, click here.
More articles on artificial intelligence:
Report: 3 reasons AI in healthcare is no longer just ‘hype’
NTT Data partners with Pieces Technologies to integrate AI into clinical analytics portfolio
Survey: Tech expertise ranks as No. 1 barrier to AI development among life science pros
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
